L-Methionine-DL-sulfoximine

CAS No. 15985-39-4

L-Methionine-DL-sulfoximine( MSX | MSO )

Catalog No. M28359 CAS No. 15985-39-4

L-Methionine-DL-sulfoximine inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 33 In Stock
100MG 47 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-Methionine-DL-sulfoximine
  • Note
    Research use only, not for human use.
  • Brief Description
    L-Methionine-DL-sulfoximine inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies.
  • Description
    L-Methionine-DL-sulfoximine inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MSX | MSO
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CCR8
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    15985-39-4
  • Formula Weight
    180.22
  • Molecular Formula
    C5H12N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 50 mg/mL (277.42 mM)
  • SMILES
    CS(=N)(=O)CC[C@H](N)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jenkins TJ, et al. Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8. J Med Chem. 2007;50(3):566-584.
molnova catalog
related products
  • DCZ0415

    DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.

  • Cyclo(Ile-Val)

    Cyclo(Ile-Val) shows moderate antifungal and weak antitumor activities in vitro.

  • DMAPP triammonium

    DMAPP triammonium (Dimethylallyl diphosphate triammonium) is one of the prerequisite substances for an isoprenoid involved in the mevalonate (MVA) pathway, which can be used in the study of metabolism-related diseases.